Traditional drug delivery methods often face challenges such as poor bioavailability, limited solubility, and non-specific distribution, which can lead to adverse side effects. Nanomedicine delivery systems address these issues by offering targeted delivery, controlled release, and the ability to cross biological barriers. This is particularly beneficial for treating cancer, neurological disorders, and infectious diseases.
